- Home
- KVHI vs HLVX Comparison
KVHI vs HLVX Comparison
Compare KVHI & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KVHI
- HLVX
- Stock Information
- Founded
- KVHI 1978
- HLVX 2020
- Country
- KVHI United States
- HLVX United States
- Employees
- KVHI N/A
- HLVX N/A
- Industry
- KVHI Radio And Television Broadcasting And Communications Equipment
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- KVHI Technology
- HLVX Health Care
- Exchange
- KVHI Nasdaq
- HLVX Nasdaq
- Market Cap
- KVHI 108.1M
- HLVX 87.6M
- IPO Year
- KVHI 1996
- HLVX 2022
- Fundamental
- Price
- KVHI $5.78
- HLVX $1.90
- Analyst Decision
- KVHI
- HLVX Hold
- Analyst Count
- KVHI 0
- HLVX 5
- Target Price
- KVHI N/A
- HLVX $2.33
- AVG Volume (30 Days)
- KVHI 56.4K
- HLVX 245.3K
- Earning Date
- KVHI 11-07-2024
- HLVX 11-07-2024
- Dividend Yield
- KVHI N/A
- HLVX N/A
- EPS Growth
- KVHI N/A
- HLVX N/A
- EPS
- KVHI N/A
- HLVX N/A
- Revenue
- KVHI $118,366,000.00
- HLVX N/A
- Revenue This Year
- KVHI N/A
- HLVX N/A
- Revenue Next Year
- KVHI N/A
- HLVX N/A
- P/E Ratio
- KVHI N/A
- HLVX N/A
- Revenue Growth
- KVHI N/A
- HLVX N/A
- 52 Week Low
- KVHI $4.17
- HLVX $1.55
- 52 Week High
- KVHI $6.00
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- KVHI 64.99
- HLVX 47.43
- Support Level
- KVHI $5.57
- HLVX $1.95
- Resistance Level
- KVHI $5.94
- HLVX $2.13
- Average True Range (ATR)
- KVHI 0.19
- HLVX 0.07
- MACD
- KVHI -0.02
- HLVX -0.00
- Stochastic Oscillator
- KVHI 74.19
- HLVX 14.81
About KVHI KVH Industries Inc.
KVH Industries Inc provide integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. The Company operates in a number of geographic areas, including internationally. The Revenues are generated from international locations, mainly consisting of Singapore, Canada, European Union countries and other European countries, countries in Africa, Asia/Pacific and the Middle East, and India.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.